Craig Rudnick, M.D.

Dr. Rudnick is a graduate of The Ohio State University College of Medicine. He completed his psychiatric residency at The University of Arizona.

Dr. Rudnick specializes in the administration of intranasal esketamine (Spravato) for patients with treatment-resistant depression—a growing focus within the practice. He also regularly utilizes buprenorphine/naloxone (Suboxone) for the treatment of opioid use disorder.

Other Areas of Clinical Expertise:

• Adult ADHD

• Mood Disorders

• Anxiety Disorders

• PTSD

• Sleep Disorders

• Substance Use Disorders